Business Description
Horien Biochemical Technology Co Ltd
ISIN : TW0007814006
Total Employee Number:
53Description
Horien Biochemical Technology Co Ltd is engaged in the research and development of cosmetic raw materials and medical devices and facilities. The products of the company include Gen-Nusis, skin repairment ingredients, PeptioMax, the latest cosmetic raw material, Lifkin, and other substitutes used in dentistry and general surgery.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 187.39 | |||||
Equity-to-Asset | 0.94 | |||||
Debt-to-EBITDA | 0.13 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 43.38 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.8 | |||||
3-Year EBITDA Growth Rate | -33.1 | |||||
3-Year Book Growth Rate | 18.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 34.46 | |||||
9-Day RSI | 36.05 | |||||
14-Day RSI | 37.53 | |||||
3-1 Month Momentum % | -7.47 | |||||
6-1 Month Momentum % | -7.36 | |||||
12-1 Month Momentum % | 34.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 12.7 | |||||
Quick Ratio | 11.61 | |||||
Cash Ratio | 10.81 | |||||
Days Inventory | 254.64 | |||||
Days Sales Outstanding | 40.59 | |||||
Days Payable | 23.47 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 69.59 | |||||
Operating Margin % | -4.46 | |||||
Net Margin % | -0.83 | |||||
EBITDA Margin % | 9.22 | |||||
FCF Margin % | -12.76 | |||||
OCF Margin % | -4.68 | |||||
ROE % | -0.26 | |||||
ROA % | -0.24 | |||||
ROIC % | -4.71 | |||||
3-Year ROIIC % | -58.21 | |||||
ROC (Joel Greenblatt) % | -0.96 | |||||
ROCE % | -0.25 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 13.07 | |||||
PB Ratio | 4.13 | |||||
Price-to-Tangible-Book | 4.16 | |||||
EV-to-EBIT | -1558.65 | |||||
EV-to-EBITDA | 135.35 | |||||
EV-to-Revenue | 12.48 | |||||
EV-to-FCF | -98.76 | |||||
| Price-to-Net-Current-Asset-Value | 5.38 | |||||
| Price-to-Net-Cash | 6.42 | |||||
Earnings Yield (Greenblatt) % | -0.06 | |||||
FCF Yield % | -0.87 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Horien Biochemical Technology Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 92.058 | ||
| EPS (TTM) (NT$) | -0.04 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 35.87 | ||
| 14-Day RSI | 37.53 | ||
| 14-Day ATR (NT$) | 2.438773 | ||
| 20-Day SMA (NT$) | 33.855 | ||
| 12-1 Month Momentum % | 34.25 | ||
| 52-Week Range (NT$) | 28 - 46 | ||
| Shares Outstanding (Mil) | 45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Horien Biochemical Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Horien Biochemical Technology Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Horien Biochemical Technology Co Ltd Frequently Asked Questions
What is Horien Biochemical Technology Co Ltd(ROCO:7814)'s stock price today?
The current price of ROCO:7814 is NT$30.10. The 52 week high of ROCO:7814 is NT$46.00 and 52 week low is NT$28.00.
When is next earnings date of Horien Biochemical Technology Co Ltd(ROCO:7814)?
The next earnings date of Horien Biochemical Technology Co Ltd(ROCO:7814) is .
Does Horien Biochemical Technology Co Ltd(ROCO:7814) pay dividends? If so, how much?
Horien Biochemical Technology Co Ltd(ROCO:7814) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Horien Biochemical Technology Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers